Lawrence A Kenyon
Director, Chief Financial Officer · 2 filings · Latest: Aug 14, 2026
Outlook Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
OTLK | Lawrence A Kenyon | Director, Chief Financial Officer | Aug 14, 2026 | Purchase | — | 101,010 | — | 106,956 |